SILVERCREST ASSET MANAGEMENT GROUP LLC
Position in TVRD — Tvardi Therapeutics, Inc.
CIK 1232395
NEW YORK, NY
Position in TVRD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$191,964
-$129,324 QoQ
Shares Held
101,034
0.0% QoQ
Ownership
0.757%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#5
of 58 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TVRD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERCREST ASSET MANAGEMENT GROUP LLC holds $128,449,389 across 20 Biotechnology names. TVRD ranks #19 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VCEL |
Vericel Corp
|
896,651 | $39,892,002 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
77,278 | $9,046,935 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
103,616 | $8,445,740 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
15,655 | $8,405,952 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
73,432 | $8,153,154 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
16,346 | $8,119,548 | |
| 7 | COGT |
Cogent Biosciences, Inc.
|
159,545 | $6,174,391 | |
| 8 | PVLA |
Palvella Therapeutics, Inc.
|
39,865 | $6,092,169 |
All Filings in TVRD
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $191,964 | 101,034 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $321,288 | 101,034 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $434,446 | 101,034 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $871,603 | 22,366 | Shares | Sole | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||